Capital Cs Group, LLC Eli Lilly & CO Transaction History

Capital Cs Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $705,186 - $827,993	-2,530 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $435,349 - $541,029	-1,855 Reduced 42.3%	2,530 $725,000
Q4 2021 Jan 20, 2022	BUY	$224.85 - $279.04 $985,967 - $1.22 Million	4,385 New	4,385 $1.21 Million

3,725

738M

7.09M

7.24M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Capital Cs Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Cs Group, LLC with notifications on news.